Tarsus Pharmaceuticals, Inc. (TARS)
NASDAQ: TARS · Real-Time Price · USD
40.89
-0.06 (-0.15%)
At close: Jun 13, 2025, 4:00 PM
42.90
+2.01 (4.92%)
After-hours: Jun 13, 2025, 6:17 PM EDT
Tarsus Pharmaceuticals Market Cap
Tarsus Pharmaceuticals has a market cap or net worth of $1.72 billion as of June 13, 2025. Its market cap has increased by 31.04% in one year.
Market Cap
1.72B
Enterprise Value
1.38B
1-Year Change
31.04%
Ranking
Category
Stock Price
$40.89
Market Cap Chart
Since the IPO on October 16, 2020, Tarsus Pharmaceuticals's market cap has increased from $308.14M to $1.72B, an increase of 457.52%. That is a compound annual growth rate of 44.59%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 13, 2025 | 1.72B | -18.83% |
| Dec 31, 2024 | 2.12B | 215.74% |
| Dec 29, 2023 | 670.37M | 71.44% |
| Dec 30, 2022 | 391.01M | -15.95% |
| Dec 31, 2021 | 465.23M | -44.60% |
| Dec 31, 2020 | 839.84M | 172.55% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 735.57B |
| Johnson & Johnson | 377.99B |
| Novo Nordisk | 355.28B |
| AbbVie | 337.52B |
| UnitedHealth Group | 284.42B |
| Abbott Laboratories | 235.96B |
| Novartis AG | 234.52B |
| AstraZeneca | 231.58B |